The Role of Psychotropic Medications in the Management of Anorexia Nervosa: Rationale, Evidence and Future Prospects

被引:39
作者
Frank, Guido K. W. [1 ,2 ,3 ,4 ]
Shott, Megan E. [1 ,2 ,3 ]
机构
[1] Univ Colorado, Childrens Hosp Colorado, Dept Psychiat, Anschutz Med Campus,Gary Pavil A036-B-130, Aurora, CO 80045 USA
[2] Univ Colorado, Childrens Hosp Colorado, Dept Neurosci, Anschutz Med Campus,Gary Pavil A036-B-130, Aurora, CO 80045 USA
[3] Univ Colorado, Childrens Hosp Colorado, Dev Brain Res Program, Anschutz Med Campus,Gary Pavil A036-B-130, Aurora, CO 80045 USA
[4] Univ Colorado Denver, Sch Med, Anschutz Med Campus, Aurora, CO USA
基金
美国国家卫生研究院;
关键词
TRANSCRANIAL MAGNETIC STIMULATION; AGONIST-INDUCED DESENSITIZATION; GENOME-WIDE ASSOCIATION; DOPAMINE D2 RECEPTORS; SHORT-TERM TREATMENT; DOUBLE-BLIND; EATING-DISORDERS; WEIGHT-LOSS; FOOD-INTAKE; OXYTOCIN SECRETION;
D O I
10.1007/s40263-016-0335-6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Anorexia nervosa (AN) is a severe psychiatric disorder without approved medication intervention. Every class of psychoactive medication has been tried to improve treatment outcome; however, randomized controlled trials have been ambiguous at best and across studies have not shown robust improvements in weight gain and recovery. Here we review the available literature on pharmacological interventions since AN came to greater public recognition in the 1960s, including a critical review of why those trials may not have been successful. We further provide a neurobiological background for the disorder and discuss how cognition, learning, and emotion-regulating circuits could become treatment targets in the future. Making every effort to develop effective pharmacological treatment options for AN is imperative as it continues to be a complex psychiatric disorder with high disease burden and mortality.
引用
收藏
页码:419 / 442
页数:24
相关论文
共 192 条
[1]   Use of Repetitive Transcranial Magnetic Stimulation for Treatment in Psychiatry [J].
Aleman, Andre .
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2013, 11 (02) :53-59
[2]  
American Psychiatric Association A. Association A.P, 2013, Diagnostic and Statistical Manual of Mental Disorders, DOI [DOI 10.1176/APPI.BOOKS.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596.744053]
[3]   Dronabinol in Severe, Enduring Anorexia Nervosa: A Randomized Controlled Trial [J].
Andries, Alin ;
Frystyk, Jan ;
Flyvbjerg, Allan ;
Stoving, Rene Klinkby .
INTERNATIONAL JOURNAL OF EATING DISORDERS, 2014, 47 (01) :18-23
[4]  
[Anonymous], J AM ACAD CHILD ADOL
[5]  
[Anonymous], NUTR METAB
[6]  
[Anonymous], BMJ CLIN EVID
[7]  
[Anonymous], [No title captured]
[8]   Omega-3 fatty acids for depression in adults [J].
Appleton, Katherine M. ;
Sallis, Hannah M. ;
Perry, Rachel ;
Ness, Andrew R. ;
Churchill, Rachel .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (11)
[9]   Treatment with 8-OH-DPAT attenuates the weight loss associated with activity-based anorexia in female rats [J].
Atchley, Deann P. D. ;
Eckel, Lisa A. .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2006, 83 (04) :547-553
[10]   Fenfluramine treatment in female rats accelerates the weight loss associated with activity-based anorexia [J].
Atchley, DPD ;
Eckel, LA .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2005, 80 (02) :273-279